Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy. Martinez-Castedo B, Camblor DG, Martin-Arana J, Carbonell-Asins JA, et al. Ann Oncol 2024 Dec 13:S0923-7534(24)04981-0. doi: 10.1016/j.annonc.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Martinez-Castedo B, Camblor DG, Martin-Arana J, Carbonell-Asins JA, et al. Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy. Ann Oncol 2024 Dec 13:S0923-7534(24)04981-0. doi: 10.1016/j.annonc.2024.
PMID: 39675560